FDANews
FDAnews Drug Daily Bulletin

PROMETIC CLOSES C$10.8 MILLION PRIVATE PLACEMENT

June 8, 2006

ProMetic Life Sciences Inc. announced today that it closed a previously announced private placement of 29,600,000 subordinate voting shares at C$0.365 per share with JPMorgan and Third Point LLC. Proceeds from the private placement totaled C$10.8 million.
Market Wire

Copyright ©2019. All Rights Reserved.
FDAnews 300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 – Fax (703) 538-7676 – Toll free (888) 838-5578
www.fdanews.com